CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Summary

Randomized phase II trial to compare the effectiveness of different doses of CCI-779 in treating patients who have extensive-stage small cell lung cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die

Timeline

Start

2002-02

Primary completion

2007-01

Completion

—

Drugs

Indications